lysophosphatidic acid has been researched along with Cancer of Prostate in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (46.88) | 29.6817 |
| 2010's | 17 (53.13) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CC; Chen, WM; Huang, YL; Jou, YC; Kanaho, Y; Lee, H; Lin, YC; Lu, KY; Ohbayashi, N; Shen, CH; Shen, TL | 1 |
| Chen, BPC; Chen, WM; Huang, YL; Lee, H; Lin, CC; Lin, YC | 1 |
| Botelho, RJ; Genc, GE; Gumuslu, S; Hipolito, VEB | 1 |
| Huang, YL; Lan, SY; Lee, H; Lin, YC; Wu, PY | 1 |
| Chen, JH; Huang, YL; Ju, TK; Lee, H; Lee, MS; Lin, CC; Lin, CE; Lin, YC | 1 |
| Clézardin, P; David, M; Descotes, F; Leblanc, R; Mege, F; Peyruchaud, O; Ribeiro, J; Sahay, D | 1 |
| Heo, SC; Jeong, GO; Kim, BR; Kim, JH; Kwon, YW; Seo, EJ; Shin, SH | 1 |
| Hwang, YS; Lee, J; Lindholm, PF; Zhang, X | 1 |
| Hwang, YS; Lindholm, PF | 1 |
| Hopkins, MM; Liu, Z; Meier, KE | 1 |
| Roper, WG | 1 |
| Kakehi, Y; Nouh, MA; Sugimoto, M; Tsunemori, H; Wu, XX; Zeng, Y | 1 |
| Hasegawa, Y; Mills, GB; Murph, M; Tigyi, G; Yu, S | 1 |
| Cantile, M; Chieffi, P; Cillo, C; Fabbrocini, G; Kisslinger, A; Mancini, FP; Sparaneo, G; Tramontano, D; Vitale, N | 1 |
| Gibbs, TC; Kipp, KR; Meier, KE; Rubio, MV; Xie, Y; Zhang, Z | 1 |
| Diamandis, EP | 1 |
| Goldsmith, PK; Heger, CD; Kelly, K; Lake, R; Merino, M; Raffeld, M; Ward, Y; Yin, JJ | 1 |
| Ahonen, I; Grafström, R; Happonen, A; Härmä, V; Kaewphan, S; Kallioniemi, O; Knuuttila, M; Kohonen, P; Kovanen, P; Lötjönen, J; Mirtti, T; Nees, M; Virtanen, J | 1 |
| Gibbs, TC; Knoepp, SM; Meier, KE; Park, JJ; Rubio, MV; Snider, AJ; Um, T; Xie, Y; Zhang, Z | 1 |
| DeFranco, DB | 1 |
| Chang, CH; Chen, SU; Lee, H; Lin, CC; Lin, CE; Lin, YC; Shen, TL; Tai, YL | 1 |
| Daaka, Y; Sivashanmugam, P; Tang, L | 1 |
| Kozasa, T; Liu, M; Neubig, RR; Rothstein, JD; Sternweis, PC; Wang, Q | 1 |
| Sengupta, S; Tipps, R; Wang, Z; Xu, Y | 1 |
| Daaka, Y; Guo, R; Madden, JF; Raj, GV; Sekula, JA | 1 |
| Bai, W; Haller, EM; Hou, H; Nicosia, SV; Yang, Y | 1 |
| Bektas, M; Goparaju, S; Liu, H; Milstien, S; Payne, SG; Spiegel, S | 1 |
| Chen, YC; Wang, Y; Xu, WR; Yu, H | 1 |
| Milstien, S; Spiegel, S | 1 |
| Chen, Y; Wang, F; Wang, Y; Xu, W; Yu, H | 1 |
| Hodge, JC; Hwang, YS; Lindholm, PF; Sivapurapu, N | 1 |
| Cui, MZ; Han, J; Hao, F; Miller, DD; Tan, M; Tigyi, G; Xu, X | 1 |
2 review(s) available for lysophosphatidic acid and Cancer of Prostate
| Article | Year |
|---|---|
Biology of LPA in health and disease.
Topics: Breast Neoplasms; Cardiovascular Physiological Phenomena; Female; Gastrointestinal Tract; Genitalia; Humans; Lysophospholipids; Male; Nervous System Physiological Phenomena; Prostatic Neoplasms | 2004 |
Critical role of acylglycerol kinase in epidermal growth factor-induced mitogenesis of prostate cancer cells.
Topics: Cell Proliferation; Cell Survival; Epidermal Growth Factor; Humans; Lysophospholipids; Male; Phosphatidic Acids; Phosphotransferases (Alcohol Group Acceptor); Prostatic Neoplasms; Receptors, G-Protein-Coupled; Signal Transduction | 2005 |
30 other study(ies) available for lysophosphatidic acid and Cancer of Prostate
| Article | Year |
|---|---|
LPA
Topics: Animals; Cell Line, Tumor; Disease Progression; Eukaryotic Initiation Factor-2; Humans; Lymphangiogenesis; Lymphatic Metastasis; Lysophospholipids; Male; Mice; Mice, Nude; Neoplasm Transplantation; Phosphoric Diester Hydrolases; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Receptors, Lysophosphatidic Acid; Signal Transduction; Vascular Endothelial Growth Factor C | 2018 |
High Glucose Induces VEGF-C Expression via the LPA1/3-Akt-ROS-LEDGF Signaling Axis in Human Prostate Cancer PC-3 Cells.
Topics: Calreticulin; Cell Line, Tumor; Glucose; Glycolysis; Humans; Intercellular Signaling Peptides and Proteins; Lysophospholipids; Male; Oxygen Consumption; Phosphoinositide Phospholipase C; Phosphoric Diester Hydrolases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Receptors, Lysophosphatidic Acid; RNA Interference; RNA, Small Interfering; Signal Transduction; Up-Regulation; Vascular Endothelial Growth Factor C | 2018 |
Lysophosphatidic acid represses autophagy in prostate carcinoma cells.
Topics: Antineoplastic Agents; Autophagy; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Lysophospholipids; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Prostatic Neoplasms; Structure-Activity Relationship; TOR Serine-Threonine Kinases; Tumor Cells, Cultured | 2019 |
Aromatic hydrocarbon receptor inhibits lysophosphatidic acid-induced vascular endothelial growth factor-A expression in PC-3 prostate cancer cells.
Topics: Angiogenesis Inducing Agents; Aryl Hydrocarbon Receptor Nuclear Translocator; Cell Line, Tumor; HEK293 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lysophospholipids; Male; Neoplasm Metastasis; Neovascularization, Pathologic; Prostatic Neoplasms; Receptors, Aryl Hydrocarbon; Signal Transduction; Vascular Endothelial Growth Factor A | 2013 |
Lysophosphatidic acid induces reactive oxygen species generation by activating protein kinase C in PC-3 human prostate cancer cells.
Topics: Cell Line, Tumor; Enzyme Activation; Humans; Lysophospholipids; Male; Prostatic Neoplasms; Protein Kinase C; Reactive Oxygen Species; Receptors, Lysophosphatidic Acid; Type C Phospholipases | 2013 |
Identification of heparin-binding EGF-like growth factor (HB-EGF) as a biomarker for lysophosphatidic acid receptor type 1 (LPA1) activation in human breast and prostate cancers.
Topics: Animals; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Heparin-binding EGF-like Growth Factor; Humans; Isoxazoles; Lysophospholipids; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Propionates; Prostatic Neoplasms; Receptors, Lysophosphatidic Acid; RNA, Messenger; Signal Transduction; Xenograft Model Antitumor Assays | 2014 |
Krüppel-like factor 4 mediates lysophosphatidic acid-stimulated migration and proliferation of PC3M prostate cancer cells.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Silencing; Humans; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lysophospholipids; Male; Mice, Inbred BALB C; Prostate; Prostatic Neoplasms | 2014 |
Lysophosphatidic acid activates the RhoA and NF-κB through Akt/IκBα signaling and promotes prostate cancer invasion and progression by enhancing functional invadopodia formation.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Disease Progression; Extracellular Matrix; Heterografts; Humans; Lysophospholipids; Male; Neoplasm Invasiveness; NF-kappa B; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; rhoA GTP-Binding Protein; Signal Transduction | 2016 |
LPA Increases Tumor Growth and Bone Destruction Through Enhancement of Osteoclastogenic Cytokines.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Culture Media, Conditioned; Cytokines; Humans; Lysophospholipids; Male; Mice, Inbred BALB C; Mice, Nude; Osteoclasts; Paracrine Communication; Prostatic Neoplasms; Signal Transduction; Skull; Skull Neoplasms; Tumor Burden; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2016 |
Positive and Negative Cross-Talk between Lysophosphatidic Acid Receptor 1, Free Fatty Acid Receptor 4, and Epidermal Growth Factor Receptor in Human Prostate Cancer Cells.
Topics: beta-Arrestin 2; Cell Movement; Cell Proliferation; Epidermal Growth Factor; ErbB Receptors; Gene Knockdown Techniques; Humans; Lysophospholipids; Male; Prostatic Neoplasms; Receptors, G-Protein-Coupled; Receptors, Lysophosphatidic Acid | 2016 |
The prevention of benign prostatic hyperplasia (bph).
Topics: Adult; Aged; Androgens; Apoptosis; Escherichia coli; Estrogens; Fatty Acids; Glycerol; Humans; Lysophospholipids; Male; Middle Aged; Models, Theoretical; Muscle, Smooth; Phosphates; Phospholipase D; Prolactin; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Sexual Behavior; Streptomyces; Testosterone | 2017 |
Gene expression profiles of lysophosphatidic acid-related molecules in the prostate: relevance to prostate cancer and benign hyperplasia.
Topics: Aged; Aged, 80 and over; Androgens; Antigens, Neoplasm; Biomarkers, Tumor; Cell Line, Tumor; Gene Expression Profiling; Humans; Lectins, C-Type; Lysophospholipids; Male; Microdissection; Middle Aged; Multienzyme Complexes; Pancreatitis-Associated Proteins; Phosphodiesterase I; Phosphoric Diester Hydrolases; Phosphotransferases (Alcohol Group Acceptor); Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Pyrophosphatases; Receptors, Lysophosphatidic Acid; RNA, Messenger; Urinary Bladder Neoplasms | 2009 |
Lysophosphatidic acid (LPA)-induced vasodilator-stimulated phosphoprotein mediates lamellipodia formation to initiate motility in PC-3 prostate cancer cells.
Topics: Cell Adhesion Molecules; Cell Line, Tumor; Cell Movement; Humans; Lysophospholipids; Male; Microfilament Proteins; Phosphoproteins; Prostatic Neoplasms; Pseudopodia; Receptors, Lysophosphatidic Acid | 2008 |
cAMP and Pyk2 interact to regulate prostate cell proliferation and function.
Topics: Bucladesine; Cell Line, Tumor; Cell Proliferation; Focal Adhesion Kinase 2; Gene Expression Regulation, Neoplastic; Genes, Homeobox; Humans; Lysophospholipids; Male; Mitogen-Activated Protein Kinase 1; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction | 2009 |
Signal transduction responses to lysophosphatidic acid and sphingosine 1-phosphate in human prostate cancer cells.
Topics: Cell Division; Cell Line, Tumor; Culture Media, Serum-Free; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; Isomerism; Lysophospholipids; Male; Phosphorylation; Prostatic Neoplasms; Receptors, Lysophosphatidic Acid; Receptors, Lysosphingolipid; RNA, Messenger; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors; Tyrosine | 2009 |
Cancer biomarkers: can we turn recent failures into success?
Topics: Animals; Antigens, Neoplasm; Biomarkers, Tumor; CA-125 Antigen; Clinical Trials as Topic; Female; Humans; Lysophospholipids; Male; Mass Screening; Mass Spectrometry; Neoplasms; Nuclear Magnetic Resonance, Biomolecular; Osteopontin; Ovarian Neoplasms; Predictive Value of Tests; Prognosis; Prostatic Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Validation Studies as Topic | 2010 |
LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells.
Topics: Antigens, CD; Cell Line, Tumor; Disease Progression; Extracellular Signal-Regulated MAP Kinases; GTP-Binding Protein alpha Subunits, G12-G13; Guanosine Triphosphate; Humans; Lysophospholipids; Male; Neoplasm Invasiveness; Neoplasm Metastasis; Prostatic Neoplasms; Receptors, G-Protein-Coupled; Receptors, Lysophosphatidic Acid; rhoA GTP-Binding Protein; Signal Transduction | 2011 |
Lysophosphatidic acid and sphingosine-1-phosphate promote morphogenesis and block invasion of prostate cancer cells in three-dimensional organotypic models.
Topics: Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Movement; Epithelium; GTP-Binding Proteins; Humans; Lysophospholipids; Male; Prostatic Neoplasms; RNA Interference; Signal Transduction; Sphingosine; Tumor Cells, Cultured | 2012 |
Effects of lysophosphatidic acid on calpain-mediated proteolysis of focal adhesion kinase in human prostate cancer cells.
Topics: Adenocarcinoma; Animals; Calpain; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Screening Assays, Antitumor; Fibroblasts; Focal Adhesion Protein-Tyrosine Kinases; Humans; Ionomycin; Isoxazoles; Lysophospholipids; Male; Paxillin; Phosphorylation; Propionates; Prostatic Neoplasms; Proteolysis; Rats; Thapsigargin | 2012 |
Editorial: Molecular Endocrinology articles in the spotlight for May 2012.
Topics: Adipogenesis; Adipose Tissue, Brown; Androgens; Animals; Carrier Proteins; Cell Cycle; Diet, High-Fat; Gene Expression Regulation, Neoplastic; Humans; Lysophospholipids; Male; Neoplasm Proteins; Neoplasm Recurrence, Local; Obesity; Phosphoric Diester Hydrolases; Prostatic Neoplasms; Receptors, Androgen; rhoA GTP-Binding Protein; Signal Transduction; Tumor Suppressor Proteins | 2012 |
Lysophosphatidic acid enhances vascular endothelial growth factor-C expression in human prostate cancer PC-3 cells.
Topics: Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Human Umbilical Vein Endothelial Cells; Humans; Intercellular Signaling Peptides and Proteins; Lysophospholipids; Male; Phosphoric Diester Hydrolases; Prostatic Neoplasms; Reactive Oxygen Species; Receptors, Lysophosphatidic Acid; Vascular Endothelial Growth Factor C | 2012 |
Interleukin 6 mediates the lysophosphatidic acid-regulated cross-talk between stromal and epithelial prostate cancer cells.
Topics: Animals; Antibodies; Cell Communication; Cell Line, Tumor; Coculture Techniques; Culture Media, Serum-Free; DNA-Binding Proteins; Enzyme Activation; Epithelial Cells; Humans; Interleukin-6; Lysophospholipids; Male; Mice; Mice, Nude; Mitogen-Activated Protein Kinases; Prostatic Neoplasms; STAT3 Transcription Factor; Stromal Cells; Trans-Activators; Transplantation, Heterologous | 2004 |
Thrombin and lysophosphatidic acid receptors utilize distinct rhoGEFs in prostate cancer cells.
Topics: Cell Line, Tumor; Cell Size; Guanine Nucleotide Exchange Factors; Humans; Lysophospholipids; Male; Prostatic Neoplasms; Protein Structure, Tertiary; Receptors, G-Protein-Coupled; Receptors, Glutamate; Receptors, Lysophosphatidic Acid; Receptors, Thrombin; Rho Guanine Nucleotide Exchange Factors; RNA, Small Interfering; Signal Transduction; Thrombin | 2004 |
Lysophosphatidic acid promotes survival of androgen-insensitive prostate cancer PC3 cells via activation of NF-kappaB.
Topics: Adenocarcinoma; Apoptosis; Cell Line, Tumor; Cell Survival; Humans; Lysophospholipids; Male; NF-kappa B; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, Androgen; Signal Transduction | 2004 |
Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation.
Topics: Acetylation; Apoptosis; Base Sequence; Cell Line, Tumor; Cell Nucleus; DNA-Binding Proteins; DNA, Neoplasm; Forkhead Box Protein O1; Forkhead Transcription Factors; Histone Deacetylases; Homeodomain Proteins; Humans; LIM-Homeodomain Proteins; Lysophospholipids; Male; Models, Biological; Muscle Proteins; Prostatic Neoplasms; Sirtuin 1; Sirtuins; Transcription Factors; Transcription, Genetic; Two-Hybrid System Techniques | 2005 |
A novel acylglycerol kinase that produces lysophosphatidic acid modulates cross talk with EGFR in prostate cancer cells.
Topics: Animals; Carcinoma; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Diglycerides; Down-Regulation; ErbB Receptors; Glycerides; Humans; Lysophospholipids; Male; Mice; Mitochondria; Mitogen-Activated Protein Kinase 3; NIH 3T3 Cells; Phosphatidic Acids; Phosphotransferases (Alcohol Group Acceptor); Prostatic Neoplasms; Rats; S Phase; Transcriptional Activation; Up-Regulation | 2005 |
[Effect of RhoA and cAMP on morphological changes in human prostate cancer cell line PC-3].
Topics: Cell Line, Tumor; Cell Shape; Cyclic AMP; Humans; Lysophospholipids; Male; Prostatic Neoplasms; rhoA GTP-Binding Protein; Signal Transduction | 2005 |
The cross talk between protein kinase A- and RhoA-mediated signaling in cancer cells.
Topics: Apoptosis Regulatory Proteins; Blotting, Western; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epithelial Cells; Escherichia coli; Gastric Mucosa; Glutathione Transferase; Green Fluorescent Proteins; GTP-Binding Proteins; Humans; Intracellular Signaling Peptides and Proteins; Lysophospholipids; Male; Microscopy, Fluorescence; Phosphorylation; Prostatic Neoplasms; Recombinant Fusion Proteins; rhoA GTP-Binding Protein; Signal Transduction; Thionucleotides | 2005 |
Lysophosphatidic acid stimulates PC-3 prostate cancer cell Matrigel invasion through activation of RhoA and NF-kappaB activity.
Topics: Cell Line, Tumor; Collagen; Drug Combinations; Humans; Laminin; Lysophospholipids; Male; Neoplasm Invasiveness; NF-kappa B; Prostatic Neoplasms; Proteoglycans; rhoA GTP-Binding Protein | 2006 |
Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38alpha.
Topics: Cell Movement; Dose-Response Relationship, Drug; Enzyme Activation; Gene Expression Regulation, Neoplastic; GTP-Binding Proteins; Humans; JNK Mitogen-Activated Protein Kinases; Lysophospholipids; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 14; Pertussis Toxin; Prostatic Neoplasms; Receptors, Lysophosphatidic Acid; RNA, Small Interfering | 2007 |